
RHOJ : contrôle de la résistance à la chimiothérapie
Cédric Blanpain's team (WEL Research Institute - ULB) discovered that RHOJ allows cancer cells with EMT to resist chemotherapy.
Cédric Blanpain's team (WEL Research Institute - ULB) discovered that RHOJ allows cancer cells with EMT to resist chemotherapy.
Thomas Marichal (WEL Research Institute - ULiège) and his team have discovered that blood monocytes, previously considered to be differentiated cells, are in fact capable of proliferating to replace tissue macrophages.
Jean-François Collet (WEL Research Institute - UCLouvain) and colleagues discovered that the chaperone GroEL works with CnoX, a chaperedoxin that controls the redox quality of GroEL substrates.
Decio L. Eizirik (WEL Research Institute - ULB) is the recipient of the prestigious George Eisenbarth Memorial Lecture that will be delivered at the 15th annual Network for Pancreatic Organ Donors with Diabetes (nPOD) meeting in Florida, USA.
The WEL Research Institute is #hiring a dynamic Business Development Manager – Sustainable Transition to create value for our society based on results that will be generated by the WEL-T fundamental research programmes.
Cédric Blanpain (WEL Research Institute - ULB) is the winner of the Momentum Award 2023 of the International Society for Stem Cell Research (ISSCR). This is the first time that such a prestigious award has been given to a researcher based in Europe.
Miikka Vikkula (WEL Research Institute - UCLouvain) is the recipient of the prestigious Earl P. Benditt Award which he will receive at the 2023 edition of the North American Vascular Biology Organization (NAVBO) meeting in Rhode Island, USA.
Alain Vanderplasschen (WEL Research Institute – ULiège) and his team demonstrated a key role for the Zalpha protein domain of Cyprinid herpesvirus 3 in the mechanism of viral infection in carp.
Sophie Lucas’ team (WEL Research Institute - UCLouvain) showed that the strategy of blocking GARP, a novel immuno-oncology target under clinical investigation for solid cancers, also has potential in "liquid" tumours.
Opening on 15 December 2022 of the first "WEL-T Investigator Programme" call.
⇒ The recording of the Dec 09 information webinar in English is available here.
The WEL Research Institute supports strategic research of excellence within its departments: WELBIO (life sciences) and WEL-T (engineering sciences, chemistry, physics) for an impact in health and sustainable transition.
La « Rentrée des Chercheuses et des Chercheurs WELBIO » fut l’occasion pour WELBIO de présenter sa stratégie et ses grands axes de développement, ainsi que quelques programmes de recherche dans différents domaines, à différents stades d’évolution.